At a glance

Older patients and poor responders often wonder whether Thailand and China use different stimulation protocols. The honest answer is that the protocol families are the same; what differs is how each clinic individualises, monitors and explains the plan.

Patients with low AMH, a low antral follicle count or a previous poor response often ask whether Thailand and China use fundamentally different stimulation protocols. In most cases they do not. The protocol families — antagonist, short or flare agonist, long agonist down-regulation, mild stimulation and natural cycle — are the same clinical tools in both countries. What varies is how an individual clinic applies them: how it reads your history, how often it monitors, when it adjusts or cancels, and how clearly it explains the reasoning.

That reframing matters because it changes what you are comparing. You are not choosing between a “Thai protocol” and a “Chinese protocol”. You are comparing how two clinical teams would individualise the same evidence base for your ovaries, your age and your previous cycles.

Why no single protocol is best for poor responders

Protocol choice depends on individual clinical factors such as age, ovarian reserve markers, prior response to stimulation and prior cycle history. No single protocol is universally superior, and this is as true in Bangkok or Shanghai as anywhere else. A protocol that suits one patient with a low AMH can be a poor fit for another with the same number, because egg quantity is only one part of the picture.

This is why a clinic that offers one fixed protocol to every low-reserve patient is worth questioning, and why a clinic that explains its reasoning is easier to compare. The useful question is not “which protocol is best?” but “why this protocol for me, and what would make you change it?”

The protocol families you will hear named

These are general descriptions of what each approach is trying to achieve. They are not recommendations, and your clinician decides what applies to you.

  • Antagonist protocol. A GnRH antagonist is introduced during stimulation to prevent premature ovulation, without the earlier down-regulation phase. It is often discussed for patients where a shorter, more flexible cycle is preferred.
  • Short or flare agonist protocol. A GnRH agonist is started at the beginning of the cycle, using the initial flare effect alongside stimulation. It is one of the options clinicians weigh for expected poor responders.
  • Long agonist protocol. Down-regulation with a GnRH agonist precedes stimulation. It is a longer schedule and is generally discussed where synchronous follicle growth is the priority.
  • Mild or mini stimulation. Lower doses and a lighter medication burden, aiming for a small number of follicles rather than a high count.
  • Natural or modified natural cycle. Relies on the single follicle a cycle produces, with minimal or no stimulation medication.

For background on how these are described in the Thai context, see IVF stimulation protocol options in Thailand. The same families appear in Chinese clinics; the naming and the default starting point may differ.

Where Thailand and China actually differ

Because both countries draw on the same international clinical literature, the meaningful differences tend to sit in service design rather than in the drugs themselves. Four areas are worth comparing directly.

1. How the protocol rationale is explained

Ask each clinic to state, in writing, why it proposes a particular protocol for you: which history items drove the choice, what response it expects, and what the alternatives were. A written rationale is far more useful than a verbal summary you have to reconstruct later. If a clinic cannot or will not put this in writing before you commit, that is information in itself.

2. Monitoring frequency and dose-adjustment triggers

Low-reserve cycles can change direction quickly. Ask how often scans and blood tests are planned, who reviews the results, and what specific findings would prompt a dose change mid-cycle. You are not asking for a guarantee — you are asking whether the plan has explicit decision points or is left to improvisation.

3. Cancellation and conversion criteria

Poor responders face a real possibility that a cycle produces fewer follicles than hoped. Ask in advance what the clinic’s criteria are for continuing, converting to a different approach, or cancelling, and what happens to fees and medication already used. Understanding this before stimulation starts makes a difficult conversation later less fraught. PGT IVF cancellation reasons in Thailand covers related preparation questions.

4. Medication cost transparency and remote consultation

Stimulation medication is a significant part of cycle cost, and pricing structures differ. Ask for an itemised estimate that separates medication, monitoring and the procedure, and ask whether a remote pre-treatment consultation is possible so you can discuss your history before travelling. For a framework, see how to compare IVF medication protocols in Thailand.

A practical comparison table

Comparison point What to ask each clinic Why it matters
Protocol rationale Why this protocol for my age, AMH, AFC and prior response? Shows whether the plan is individualised
Monitoring plan How often, and what triggers a dose change? Reveals how responsive the cycle will be
Stop/conversion rules What would make you cancel or convert? Reduces surprises and cost uncertainty
Medication estimate Itemised medication versus procedure costs? Allows like-for-like quote comparison
Remote consultation Can we discuss my history before I travel? Supports planning and travel decisions

Preparing records that make protocol discussion possible

The quality of a protocol discussion depends heavily on what the clinician can see. Before approaching clinics in either country, assemble a dated record set: AMH and other hormone results with dates, antral follicle counts from ultrasound reports, previous stimulation protocols with starting doses, follicle counts at trigger, eggs retrieved and embryos obtained, and any prior cycle outcomes. If a previous cycle was cancelled, the reason recorded at the time is especially valuable.

Where records are incomplete, list the gaps explicitly rather than guessing. A clinic can work with a known gap; it cannot correct a wrong number. If you would like help organising records and putting questions to a hospital, Thailand PGT can coordinate that — clinicians interpret the results, and sharing happens only with your agreed recipient and method.

Planning travel around monitoring

Stimulation involves repeated monitoring appointments, so the practical question is where the early part of the cycle happens. Some patients arrange initial monitoring at home and travel for later stages; others prefer to be in the treatment city throughout. Ask each clinic which appointments must be in person, what local monitoring it will accept, and how results are transmitted. Build travel dates around the monitoring schedule the clinic confirms, not around an assumed timeline, and keep the return-home handoff in view: request your cycle records and a written summary before you leave.

Questions to carry into both consultations

  1. Given my age, AMH, antral follicle count and prior response, which protocol would you propose, and why?
  2. What alternatives did you consider, and what would make you switch?
  3. How many monitoring visits should I expect, and can any be done locally?
  4. What are your criteria for cancelling or converting a cycle?
  5. Can you provide an itemised medication and monitoring estimate?
  6. Can we hold a remote consultation before I book travel?
  7. What written protocol rationale and cycle records will I receive?

If you are still at the stage of researching where to be treated, the countrywide comparison of IVF hospitals and clinics in Thailand is a neutral starting point for shortlist research; it is an editorial comparison, not evidence that any provider achieves better outcomes. For the low-reserve context specifically, IVF in Thailand with low ovarian reserve and why egg number is only one part of the discussion are useful companions.

PGT-A may enter the conversation if you are considering embryo testing, but it is a separate decision from stimulation protocol. It assesses chromosome number in cells sampled from an embryo, has limitations and can produce incorrect findings, and whether to use it should be discussed for your individual situation. A result does not guarantee a successful pregnancy or a healthy child. Protocol choice and testing decisions should each be discussed with your treating clinician on their own merits.

Frequently asked questions

Does Thailand use a different stimulation protocol from China for low ovarian reserve?

The protocol families are the same in both countries — antagonist, short or flare agonist, long agonist, mild stimulation and natural cycle. Differences usually lie in how a clinic individualises the plan, how often it monitors, when it adjusts or cancels, and how clearly it explains the reasoning. Ask each clinic for a written rationale rather than assuming a national difference.

Is the antagonist protocol better than a short protocol for poor responders?

There is no universally superior protocol for poor responders. Choice depends on individual factors such as age, ovarian reserve markers, prior response and prior cycle history. Your clinician can explain which option fits your situation and what would prompt a change.

Evidence trail

Sources & verification

Review current primary information and reconfirm provider services, fees and eligibility before booking.

01HFEA: Pre-implantation genetic testing for aneuploidy (PGT-A) ↗

Your next practical step

Bring your coordination questions.

Ask about appointments, records, travel or the practical arrangements for your visit.

Ask about coordination support →